Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial

Adolescent girls and young women (AGYW) in sub-Saharan Africa may benefit from pre-exposure prophylaxis (PrEP), yet stigma may limit PrEP acceptance and continuation. We examined factors associated with PrEP use stigma among 307 participants of the EMPOWER trial (2016–2018), an unblinded randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Munthali, R. J., Stangl, A. L., Baron, D., Barré, I., Harvey, S., Ramskin, L., Colombini, M., Naicker, N., Kapiga, S., Delany-Moretlwe, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640431/
https://www.ncbi.nlm.nih.gov/pubmed/35776254
http://dx.doi.org/10.1007/s10461-022-03721-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640431/
https://www.ncbi.nlm.nih.gov/pubmed/35776254
http://dx.doi.org/10.1007/s10461-022-03721-6

Ejemplares similares